Evidence map›Paper›PMID 26112727›Full record

ReviewChinese medical journal2015

Currently Clinical Views on Genetics of Wilson's Disease.

Chen Chen, Bo Shen, Jia-Jia Xiao, Rong Wu, Sarah Jane Duff Canning, Xiao-Ping Wang

Open access · goldAbstract readReview
In one paragraph

Review in Chinese medical journal, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
2.7field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 38 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Mutational analysis of exon 8 and exon 14 of ATP7B gene in Bangladeshi children with Wilson disease.Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology · 2022
    Article
  10. Mutation spectrum ofMolecular genetics and metabolism reports · 2022
    Article
  11. Article
  12. A Novel Mutation ofMedicina (Kaunas, Lithuania) · 2021
    Article
  13. Article
  14. Article
  15. Review
  16. Observational
  17. Article
  18. The six metal binding domains in human copper transporter, ATP7B: molecular biophysics and disease-causing mutations.Biometals : an international journal on the role of metal ions in biology, biochemistry, and medicine · 2017
    Review
  19. Insights into the management of Wilson's disease.Therapeutic advances in gastroenterology · 2017
    Review
  20. Wilson's Disease in China.Neuroscience bulletin · 2017
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Chen Chen
Bo Shen
Jia-Jia Xiao
Rong Wu
Sarah Jane Duff Canning
Xiao-Ping WangDepartment of Neurology, Shanghai General Hospital, Shanghai Jiao-Tong University, Shanghai 200080, China.
Shanghai First People's Hospital · CNShanghai Jiao Tong University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveThe objective of this study was to review the research on clinical genetics of Wilson's disease (WD). DATA SOURCES: We searched documents from PubMed and Wanfang databases both in English and Chinese up to 2014 using the keywords WD in combination with genetic, ATP7B gene, gene mutation, genotype, phenotype. STUDY SELECTION: Publications about the ATP7B gene and protein function associated with clinical features were selected.

resultsWilson's disease, also named hepatolenticular degeneration, is an autosomal recessive genetic disorder characterized by abnormal copper metabolism caused by mutations to the copper-transporting gene ATP7B. Decreased biliary copper excretion and reduced incorporation of copper into apoceruloplasmin caused by defunctionalization of ATP7B protein lead to accumulation of copper in many tissues and organs, including liver, brain, and cornea, finally resulting in liver disease and extrapyramidal symptoms. It is the most common genetic neurological disorder in the onset of adolescents, second to muscular dystrophy in China. Early diagnosis and medical therapy are of great significance for improving the prognosis of WD patients. However, diagnosis of this disease is usually difficult because of its complicated phenotypes. In the last 10 years, an increasing number of clinical studies have used molecular genetics techniques. Improved diagnosis and prediction of the progression of this disease at the molecular level will aid in the development of more individualized and effective interventions, which is a key to transition from molecular genetic research to the clinical study.

conclusionsClinical genetics studies are necessary to understand the mechanism underlying WD at the molecular level from the genotype to the phenotype. Clinical genetics research benefits newly emerging medical treatments including stem cell transplantation and gene therapy for WD patients.

Indexed as

Adenosine TriphosphatasesCation Transport ProteinsCopper-Transporting ATPasesHepatolenticular DegenerationHumansPhenotypeAdenosine TriphosphatasesATP7B protein, humanCation Transport ProteinsCopper-Transporting ATPases

Identifiers

PMID26112727
PMCPMC4733722
OpenAlexW1835326675

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.